JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199357

Anti-DR5 antibody [EPR19310]

5

(5 리뷰들)

|

(19 제품이 사용된 논문 )

Rabbit Recombinant Monoclonal DR5 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 19 publications.

대체 명칭 보기

CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2

8 이미지
Flow Cytometry (Intracellular) - Anti-DR5 antibody [EPR19310] (AB199357)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-DR5 antibody [EPR19310] (AB199357)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5with ab199357 at 1/70 dilution (red) compared with aRabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining on HCT 116 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HT1080 (Human fibrosarcoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HT1080 cells. The nuclear counter stain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
  • IP

Supplier Data

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)

DR5 was immunoprecipitated from 0.35mg of HT1080 (Human fibrosarcoma cell line) treated with 5μM MG132 for 4 hour whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HT1080 treated with 5μM MG132 for 4 hour whole cell lysate, 10μg (Input).

Lane 2 : ab199357 IP in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)

Predicted band size: 47 kDa

false

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
  • IP

Supplier Data

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)

DR5 was immunoprecipitated from 0.35mg of HCT 116 (Human colorectal carcinoma cell line) whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HCT 116 whole cell lysate, 10μg (Input).

Lane 2 : ab199357 IP in HCT 116 whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HCT 116 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)

Predicted band size: 47 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1-2 : 3 minutes; Lane 3 : 10 seconds; Lane 4 : 8 seconds.

The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Human melanoma lysate at 10 µg

Lane 2:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg

Lane 4:

HT1080 (Human fibrosarcoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 47 kDa

Observed band size: 40 kDa,48 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Blocking/Dilution buffer : 5% NFDM/TBST.

Doxorubicin treatment elevated the expression of DR5 (PMID : 12496481; PMID : 11468181; PMID : 11090076). The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Untreated HCT 116 (Human colorectal carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

HCT 116 (Human colorectal carcinoma cell line) treated with 0.5μM/ml doxorubicin for 24 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 47 kDa

Observed band size: 40 kDa,48 kDa

false

Exposure time: 8s

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Lab

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Western blot : Anti-DR5 antibody [EPR19310] ab199357 staining at 1/1000 dilution, shown in green; Mouse anti-CANX ab238078 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 37-50 kDa in Wild-type HeLa cell lysates with no signal observed at this size in TNFRSF10B knockout HeLa cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysates at 20 µg

Lane 2:

Western blot - Human TNFRSF10B (DR5) knockout HeLa cell line (<a href='/ko/products/cell-lines/human-tnfrsf10b-dr5-knockout-hela-cell-line-ab264922'>ab264922</a>) at 20 µg

Lane 3:

HepG2 cell lysates at 20 µg

Lane 4:

HCT 116 cell lysates at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 47 kDa

Observed band size: 37-50 kDa

false

관련 conjugated 항체와 다양한 조성의 항체 (1)

  • Carrier free

    Anti-DR5 antibody [EPR19310] - BSA and Azide free

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19310

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt (Intra), WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/70", "FlowCytIntra-species-notes": "<p></p>" } } }

제품 세부 정보

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

DR5 also known as Death Receptor 5 TRAIL-R2 or TNFRSF10B is a protein critical in apoptosis. It is a transmembrane receptor with a mass of approximately 54 kDa. Researchers find it expressed mostly in tissues such as lung colon and prostate. DR5 functions by binding to its ligand TRAIL triggering the extrinsic apoptotic pathway. Through this mechanism DR5 initiates a cascade of caspase activation that leads to cell death.
Biological function summary

DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.

Pathways

DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.

DR5 exhibits significant relevance to cancer and autoimmune diseases. Its ability to induce apoptosis through the TRAIL pathway keeps oncogenic transformations in check. In cancer DR5 often interfaces with other proteins like Bcl-2 which are involved in cell survival. Furthermore defects or aberrant expressions in DR5 have associations with autoimmune disorders where excessive cell death or survival contributes to disease pathology. DR5's role in these conditions makes it a promising target in therapeutic strategies.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed : 10549288). The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis.
See full target information TNFRSF10B

제품이 사용된 논문 (19)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Avicenna journal of phytomedicine 14:64-77 PubMed38948179

2024

The modulating effects of astaxanthin on apoptosis in women with polycystic ovarian syndrome: A randomized clinical trial.

Applications

Unspecified application

Species

Unspecified reactive species

Masoome Jabarpour,Ashraf Aleyasin,Maryam Shabani Nashtaei,Mahshad Khodarahmian,Sara Lotfi,Fardin Amidi

Journal of biochemical and molecular toxicology 38:e23757 PubMed38937960

2024

Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through upregulation of death receptor 5.

Applications

Unspecified application

Species

Unspecified reactive species

Yunyun Zhang,Linlin Wang,Chuxuan Dong,Yahui Zhuang,Gangping Hao,Fengze Wang

World journal of gastroenterology 29:1875-1898 PubMed37032730

2023

Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Xing Hu,Zhuo Liu,Zhen Zhang,Zhe Deng,Zhen Huang,Ting Feng,Qing-Hong Zhou,Si Mei,Chun Yi,Qing Zhou,Pu-Hua Zeng,Gang Pei,Sha Tian,Xue-Fei Tian

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 34:211-220 PubMed36511604

2022

Raw Lacquer Extract from Toxicodendron vernicifluum in Combination with ONC201 Enhances the Inhibitory Effects on Colorectal Cancer Cell Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhezhu Jin,Yongjun Jin

Bioengineered 12:11213-11224 PubMed34845969

2021

Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Qiang Zhou,Jianxia Yuan,Yi Liu,Yayun Wu

Cell reports 37:109953 PubMed34731630

2021

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Gururaj Shivange,Tanmoy Mondal,Evan Lyerly,Sanchita Bhatnagar,Charles N Landen,Shivani Reddy,Jonathan Kim,Britney Doan,Paula Riddle,Jogender Tushir-Singh

PloS one 16:e0246733 PubMed33661931

2021

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.

Applications

Unspecified application

Species

Unspecified reactive species

Korie A Grayson,Nidhi Jyotsana,Nerymar Ortiz-Otero,Michael R King

Molecular cancer therapeutics 20:833-845 PubMed33632873

2021

Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Korie A Grayson,Jacob M Hope,Wenjun Wang,Cynthia A Reinhart-King,Michael R King

Cytotechnology 73:63-70 PubMed33505114

2021

Encorafenib enhances TRAIL-induced apoptosis of colorectal cancer cells dependent on p53/PUMA signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenqing Sun,Zhigang Qiu,Bin Ma,Zhengkun Wang

Frontiers in pharmacology 11:522729 PubMed33071777

2020

Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Li,Qingsen Ran,Lidong Sun,Jie Yin,Ting Luo,Li Liu,Zheng Zhao,Qing Yang,Yujie Li,Ying Chen,Xiaogang Weng,Yajie Wang,Weiyan Cai,Xiaoxin Zhu
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com